Target epitopes of myelin basic protein specific T cell lines in multiple sclerosis. 1993

G Ristori, and M Salvetti, and C Buttinelli, and M Falcone, and S Trabace, and C Fieschi
Dipartimento di Scienze Neurologiche, Università La Sapienza, Roma.

A highly efficient new method for the generation of antigen specific T cell lines (TCL) is now available. By this method we established 134 myelin basic protein (MBP) TCL from the peripheral blood of 9 patients with definite multiple sclerosis (n = 69) and 8 healthy donors (n = 65). The yield of MBP reactive TCL in the two groups was comparable. So far 22 MBP specific TCL from 7 patients and 24 from 7 healthy individuals have been tested for their proliferative response to a panel of four synthetic peptides representing MBP residues 7-26, 80-99, 139-153 and 148-162. Although the peptide sequences did not encompass the whole MBP, the pattern of reactivity to these peptides in patients and controls seems to be similar. Further, when multiple TCL from the same donor were analysed, no dominant recognition emerged.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D004676 Myelin Basic Protein An abundant cytosolic protein that plays a critical role in the structure of multilamellar myelin. Myelin basic protein binds to the cytosolic sides of myelin cell membranes and causes a tight adhesion between opposing cell membranes. Golli-MBP1 Protein,Golli-MBP2 Protein,HOG5 Protein,HOG7 Protein,MBP1 Protein,MBP2 Protein,MBP3 Protein,MBP4 Protein,Myelin Basic Protein, 17.2 kDa Isoform,Myelin Basic Protein, 18.5 kDa Isoform,Myelin Basic Protein, 20.2 kDa Isoform,Myelin Basic Protein, 21.5 kDa Isoform,Myelin Basic Protein, Isoform 1,Myelin Basic Protein, Isoform 2,Myelin Basic Protein, Isoform 3,Myelin Basic Protein, Isoform 4,Myelin Basic Protein, Isoform 5,Myelin Basic Protein, Isoform 6,Myelin Basic Protein, Isoform 7,Golli MBP1 Protein,Golli MBP2 Protein
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

G Ristori, and M Salvetti, and C Buttinelli, and M Falcone, and S Trabace, and C Fieschi
January 1992, Cellular immunology,
G Ristori, and M Salvetti, and C Buttinelli, and M Falcone, and S Trabace, and C Fieschi
January 1994, Journal of neuroimmunology,
G Ristori, and M Salvetti, and C Buttinelli, and M Falcone, and S Trabace, and C Fieschi
April 1992, European journal of immunology,
G Ristori, and M Salvetti, and C Buttinelli, and M Falcone, and S Trabace, and C Fieschi
June 1991, European journal of immunology,
G Ristori, and M Salvetti, and C Buttinelli, and M Falcone, and S Trabace, and C Fieschi
March 1993, Journal of clinical immunology,
G Ristori, and M Salvetti, and C Buttinelli, and M Falcone, and S Trabace, and C Fieschi
December 1991, Annals of the New York Academy of Sciences,
G Ristori, and M Salvetti, and C Buttinelli, and M Falcone, and S Trabace, and C Fieschi
April 2000, Multiple sclerosis (Houndmills, Basingstoke, England),
G Ristori, and M Salvetti, and C Buttinelli, and M Falcone, and S Trabace, and C Fieschi
December 1993, The Journal of clinical investigation,
G Ristori, and M Salvetti, and C Buttinelli, and M Falcone, and S Trabace, and C Fieschi
January 1999, Annals of neurology,
G Ristori, and M Salvetti, and C Buttinelli, and M Falcone, and S Trabace, and C Fieschi
October 1993, Annals of neurology,
Copied contents to your clipboard!